BioSpace News Archive

ILC Dover LP, specializing in the innovative design and production of single-use flexible solutions for global pharmaceutical and biopharmaceutical processing, introduced the soloPURE™ flexible aseptic isolator, a cost-effective, closed-barrier system for sterile manufacturing.

Risk-sharing arrangement with NovaQuest and Bain Capital will fund the full tavapadon Phase 3 development program for Parkinson’s disease through planned NDA submission

Avenue Therapeutics, Inc., a company focused on the development of intravenous tramadol for the U.S. market, announced that the U.S. Food and Drug Administration was still reviewing its New Drug Application for IV tramadol and had not provided a decision regarding the NDA.

Immunic, Inc., a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, announced participation in the following scientific, investor and industry conferences in April

Adicet Bio, Inc., a biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases, announced the appointment of Blake Aftab, Ph.D., as Vice President of Research.

Arcellx, a privately held clinical-stage biopharmaceutical company, announced that it raised $115 million in a Series C financing to advance its pipeline of adaptive and controllable cell therapies.

Post hoc analysis showed a 46% decrease in mean lesion growth in eight patients with bilateral GA comparing treated eye vs. untreated fellow eye at 24 months (p=0.007)

Landos Biopharma, a clinical-stage biopharmaceutical company focused on the discovery and development of therapeutics for patients with autoimmune diseases, announced the appointment of Tiago Girão to its Board of Directors.

Qilian International Holding Group Limited, a China-based pharmaceutical and chemical products manufacturer, announced that 16 of its products have been included in the latest version of the National Reimbursement Drugs List in China, such as aspirin enteric-coated tablets for coronary heart disease treatment, and nitrofurantoin enteric-coated tablets for the treatment of urinary tract infections.

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that its BD MAX™ Molecular Multi-Drug Resistant Tuberculosis (MDR-TB) Assay was included in the moderate complexity automated NAAT class of molecular diagnostic technologies that were recognized for high diagnostic accuracy for tuberculosis testing by the World Health Organization (WHO)